[Clinically rare subtypes of prostate cancer: Progress in research]
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This review covers rare prostate cancer subtypes, highlighting their aggressive nature and limited treatment options. Early diagnosis and targeted therapies are crucial for improving patient survival rates.
Area Of Science
- Urology
- Oncology
- Genetics
Background
- Prostate cancer is the most common male urinary tract tumor.
- Rare prostate cancer subtypes exhibit aggressive progression, metastasis, and resistance to endocrine therapy.
- These subtypes are associated with poorer patient survival compared to common prostate adenocarcinoma.
Conclusions
- Rare prostate cancer subtypes require specialized diagnostic and therapeutic approaches.
- Advancements in genetic testing and targeted therapies offer potential for improved outcomes.
- Further research is needed to fully understand and combat these aggressive forms of prostate cancer.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...